"The results present that FIGO AUB System 2 (PALM-COEIN) is widely recognised globally, but many trainees lack formal ...

In 2022, the World Health Organization (WHO) updated its Abortion care guideline, widening its scope to include ...

FIGO regularly issues statements and joint statements.

Affirming that improvements in women's health need more than better science and health care; they require state action to correct injustices to women. Recognising that women's health is often ...

The 2021 edition of the FIGO Cancer Report contains updates on the management of gynaecological cancers combined with pertinent papers on gynaecological oncology, which we hope the reader will find ...

The project ended in India and Sri Lanka in December 2018, Nepal in June 2019, Kenya in September 2019, Tanzania in March 2020 and in Bangladesh in October 2020. Across 48 Referral Hospitals, the ...

FIGO regards reproductive choice, including access to safe abortion services, as a basic and non-negotiable tool for ensuring the human rights of every woman, not just in one region or country, but ...

Worldwide, the growing use of contraceptive methods has led to a reduction in maternal and infant mortality, improvements in socio-economic conditions and increased schooling for girls and women.

May 2019, FIGO released Guidelines to combat pre-eclampsia, and calls for all women to receive first-trimester screening. Read the Pre-eclampsia Guidelines here. 76,000 women and 500,000 babies die ...

FIGO Divisions and Committees bring together experts from our member societies with other health care professionals focusing on specialist areas of obstetrics and gynaecology to encourage global ...

With a 15% prevalence of subfertility globally, the FIGO Committee on Reproductive Medicine, Endocrinology and Infertility addresses the important issue of infertility in sexual and reproductive ...

The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).